Also from this source

You just read:

Liquid Biopsy Biomarker Identifies Patients with Improved Response to PARP Inhibition in Metastatic Castrate Resistant Prostate Cancer

News provided by

Epic Sciences

Nov 16, 2016, 02:00 EST